Exforge and Foetal exposure during pregnancy - a phase IV clinical study of FDA data

Summary:

Foetal exposure during pregnancy is reported as a side effect among people who take Exforge (amlodipine besylate; valsartan), especially for people who are 0-1 old, have been taking the drug for 1 - 6 months also take Amlodipine, and have Gestational diabetes.

The phase IV clinical study analyzes which people have Foetal exposure during pregnancy when taking Exforge. It is created by eHealthMe based on reports of 12,942 people who have side effects when taking Exforge from the FDA, and is updated regularly.

What is Exforge?

Exforge has active ingredients of amlodipine besylate; valsartan. It is often used in high blood pressure. eHealthMe is studying from 13,350 Exforge users. Check the latest studies of Exforge.

What is Foetal exposure during pregnancy?

Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect) is found to be associated with 1,076 drugs and 1,131 conditions by eHealthMe. Check the latest studies of Foetal exposure during pregnancy.

On Jul, 23, 2026

12,942 people reported to have side effects when taking Exforge.
Among them, 17 people (0.13%) have Foetal exposure during pregnancy.

Could Exforge cause Foetal exposure during pregnancy?

Among these 17 people:

How long have people been on Exforge when they have Foetal exposure during pregnancy? *

What is the age of people who have Foetal exposure during pregnancy when taking Exforge? *

What are other drugs people take besides Exforge? *

What are other side effects people have besides Foetal exposure during pregnancy? *

Aortic Stenosis (obstruction to the outflow of blood from the left ventricle into the aorta): 5 people, 29.41%
Premature Baby: 3 people, 17.65%
Anuria (failure of the kidneys to produce urine): 2 people, 11.76%
Low Birth Weight Baby: 2 people, 11.76%
Foetal Distress Syndrome (altered heart rate or rhythm and leading tocompromised blood flow or changes in blood chemistry of foetus): 2 people, 11.76%
Urinary Retention (the inability to completely or partially empty the bladder): 1 person, 5.88%
Foetal Disorder (fetus disease): 1 person, 5.88%
Hydrocephalus (water on the brain): 1 person, 5.88%
Haemorrhage Intracranial (bleeding within the skull): 1 person, 5.88%
Haemoglobin Decreased: 1 person, 5.88%

What are the existing conditions these people have? *

Post-Traumatic Stress Disorder: 1 person, 5.88%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 5.88%
Gestational Diabetes (diabetes in pregnancy): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Exforge and have Foetal exposure during pregnancy?

- Check whether Foetal exposure during pregnancy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Exforge:

Exforge (13,350 reports)

Foetal exposure during pregnancy treatments and more:

Foetal exposure during pregnancy (92,006 reports)

How severe was Foetal exposure during pregnancy and when was it recovered:

Foetal exposure during pregnancy in Exforge

Expand to all the drugs that have ingredients of amlodipine besylate; valsartan:

Foetal exposure during pregnancy and drugs with ingredients of amlodipine besylate; valsartan

Sub-studies by age:

0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Exforge:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Foetal exposure during pregnancy:

Foetal exposure during pregnancy (1,076 drugs)

Browse all the conditions that are associated with Foetal exposure during pregnancy:

Foetal exposure during pregnancy (1,131 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate; valsartan (the active ingredients of Exforge) and Exforge (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.